Table 2 Patients’ characteristics (n = 14)
Age (median, years) | 68 |
|---|---|
Range (years) | 51–78 |
Sex | |
• Male | 11 (78.5) |
• Female | 3 (21.5) |
Histology | |
• Adenocarcinoma | 12 (85.6) |
• Squamocellular | 2 (14.4) |
Pathological Stage | |
• IB | 2 (14.4) |
• IIA | 6 (42.8) |
• IIIA | 6 (42.8) |
Neoadjuvant Chemotherapy | |
• Platinum-based | 5 (35.7) |
• No | 9 (64.3) |
Initial surgery | |
• Lobectomy + LAD | 13 (92.8) |
• Atypical resection + LAD | 1 (7.2) |
Adjuvant Chemotherapy | |
• Platinum-based | 8 (57.2) |
• Vinorelbine monotherapy | 1 (7.1) |
• No | 5 (35.7) |
N° of pathological nodal stations involved at diagnosis | |
0 | 2 (14.3) |
1 | 6 (42.8) |
2 | 3 (21.5) |
3 | 1 (7.1) |
4 | 2 (14.3) |